# Saline Versus Albumin Fluid for Extracorporeal Removal With Slow Low Efficiency Dialysis Feasibility Study

> **NCT03665311** · PHASE2 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 60 (actual)

## Conditions studied

- Renal Replacement Therapy
- Acute Kidney Injury
- Hypotension

## Interventions

- **BIOLOGICAL:** 25% Albumin fluid
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT03665311
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-25
- **Primary completion:** 2020-01-15
- **Final completion:** 2020-01-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03665311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03665311, "Saline Versus Albumin Fluid for Extracorporeal Removal With Slow Low Efficiency Dialysis Feasibility Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03665311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*